| Name | Judges Scientific |
|---|---|
| Epic | JDG |
| Isin | GB0032398678 |
| Index | MID300 |
| Industry | Industrial Engineering |
| Latest share price | 5,795.00p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £385.34 | Debt ratio | n/a |
| Shares in issue | 6.65 | Debt-to-equity ratio | n/a |
| P/E ratio | 29.8 | Assets / equity ratio | n/a |
| Total dividends per share | 32.70p | Price to book value | n/a |
| Dividend yield | 1.2 | ROCE | 22.66 |
| Dividend cover | 2.71 | EPS growth | -24 |
| Earning per share | 156.7 | 52-week high / low | 5,700.00p / 10,300.00p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Interim | 2025-10-09 | 2025-11-07 | 32.70p |
| Final | 2025-06-12 | 2025-07-11 | 74.80p |
| Interim | 2024-10-10 | 2024-11-08 | 29.70p |
| Final | 2024-06-06 | 2024-07-05 | 68.00p |
| Interim | 2023-10-05 | 2023-11-03 | 27.00p |
| Final | 2023-06-08 | 2023-07-07 | 59.00p |
| Interim | 2022-10-06 | 2022-11-04 | 22.00p |
| Final | 2022-06-09 | 2022-07-08 | 47.00p |
| Interim | 2021-10-07 | 2021-11-05 | 19.00p |
| Company name | Judges Scientific |
|---|---|
| Address | 52C Borough High Street, London, United Kingdom, SE1 1XN |
| Telephone | +44 (0)203 829 6970 |
| Website | http://www.judges.uk.com/ |
| Director | Position |
|---|---|
| Mr David Cicurel | CEO |
| Ms Susan Nyman | Non-Executive Director |
| Mr Ralph Elman | Non-Executive Chairman |
| Mr Bradley Leonard Ormsby | Group Finance Director |
| Ms Lushani Kodituwakku | Independent Non-Executive Director |
| Mr Charles Holroyd | Independent Non-Executive Director |
| Dr Ian Wilcock | Group Commercial Director |
| Dr Tim Prestidge | Group Business Development Director |
| Assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Reporting date | 31/12/24 | 31/12/23 | 31/12/22 |
| Intangible asssets and goodwill | 97.1 | 90.4 | 98 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 128.9 | 118.2 | 119.3 |
| Inventory / work in progress | 28.1 | 26.5 | 22.3 |
| Trade and other receivables | 30.2 | 25.1 | 25.6 |
| Cash and equivalents | 17.9 | 13.7 | 20.8 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 205.1 | 183.5 | 188 |
| Liabilities £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Short term liabilities | 33.5 | 35 | 71.8 |
| Long term liabilities | 84.4 | 65.9 | 61.7 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 117.9 | 100.9 | 133.5 |
| Net assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net assets | 87.2 | 82.6 | 54.5 |
| Equity £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Share capital | 0.3 | 0.3 | 0.3 |
| Minority interests | 0.3 | 0.2 | 0.2 |
| Retained earnings | 40.9 | 37.5 | 32.7 |
| Share premium account | 19.2 | 17.7 | 17.2 |
| Total equity | 87.2 | 82.6 | 54.5 |
| Income £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 16.7 | 21.6 | 18.2 |
| Pre-tax profit | 13 | 13.4 | 16 |